CITIC Securities: Turning Point in Medical Device Sector Performance Evident, Bullish on 2027 Investment Opportunities

36Kr reports that a CITIC Securities research note states that the A-share Shenwan medical device index has declined continuously from 2021 to 2024 due to factors such as consumables centralized procurement and heightened medical compliance requirements. In 2025, it rose first before falling, and rebounded in early 2026 before declining again. As policy impacts gradually clear and corporate strategies adjust, performance recovery is underway, ushering in a dual repair of valuation and earnings for the medical device sector. Key focus should be on companies expected to achieve growth and sustained improvement in performance by 2027, which may realize a double-digit boost in both earnings and valuation. It is anticipated that the impacts of centralized procurement and price reduction policies for multiple high-value consumables and IVD sectors will gradually clear by year-end or early next year, making sector-wide investment opportunities increasingly prominent.